Evaluating a CFT Group for Adults With Acquired Brain Injury
Launched by KING'S COLLEGE LONDON · Mar 11, 2024
Trial Information
Current as of July 12, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new therapy group called Compassion Focused Therapy (CFT) for adults who have had a brain injury, like a stroke. After a brain injury, many people struggle with feelings of anxiety and depression. The aim of this study is to see if attending a CFT group can help improve emotional well-being by teaching participants how to be kinder to themselves and manage their distress. The group will consist of 4 to 6 people and will meet once a week for six weeks at a rehabilitation center. Researchers will see how well the group runs, how many people join, and what the participants think about the experience.
To be eligible for the trial, participants must be at least 18 years old, have had a non-progressive brain injury, and currently experience some emotional distress. They should also be able to understand and consent to participate in the group. Participants will complete questionnaires before and after the group sessions to help measure any changes in their emotional health and quality of life. This study is part of a doctoral research project at King’s College London, and right now, it is not yet open for recruitment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Has experienced a non-progressive acquired brain injury
- • 2. Is at least 18 years old
- • 3. Has capacity to consent to take part in the group and associated research project
- • 4. Is currently experiencing emotional distress, as identified descriptively by the treating team and indicated by a minimum score of 8 or above (mild symptoms) on the HADS.
- Exclusion Criteria:
- • 1. Has a \[severe\] cognitive impairment to a degree that this is considered by the treating team to prevent their ability to participate in the group despite adaptations.
- • 2. Has a \[severe\] communication impairment to a degree that is considered by the treating team to prevent their ability to participate in or understand the group content despite adaptations.
- • 3. Is currently experiencing a severe mental health disorder or crisis that would impact on their ability to participate in the group.
About King's College London
King's College London is a prominent research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the college leverages its extensive expertise in medicine, neuroscience, and public health to conduct rigorous studies aimed at improving patient outcomes. As a sponsor of clinical trials, King's College London prioritizes ethical standards, participant safety, and scientific integrity, fostering an environment that encourages groundbreaking research and the translation of findings into clinical practice. Through its state-of-the-art facilities and a diverse network of researchers, the institution strives to address critical health challenges and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported